PT - JOURNAL ARTICLE AU - Andrea Pilotto AU - Alberto Benussi AU - Ilenia Libri AU - Stefano Masciocchi AU - Loris Poli AU - Enrico Premi AU - Antonella Alberici AU - Enrico Baldelli AU - Sonia Bonacina AU - Laura Brambilla AU - Matteo Benini AU - Salvatore Caratozzolo AU - Matteo Cortinovis AU - Angelo Costa AU - Stefano Cotti Piccinelli AU - Elisabetta Cottini AU - Viviana Cristillo AU - Ilenia Delrio AU - Massimiliano Filosto AU - Massimo Gamba AU - Stefano Gazzina AU - Nicola Gilberti AU - Stefano Gipponi AU - Marcello Giunta AU - Alberto Imarisio AU - Paolo Liberini AU - Martina Locatelli AU - Francesca Schiano di Cola AU - Renata Rao AU - Barbara Risi AU - Luca Rozzini AU - Andrea Scalvini AU - Veronica Vergani AU - Irene Volonghi AU - Nicola Zoppi AU - Barbara Borroni AU - Mauro Magoni AU - Matilde Leonardi AU - Gianluigi Zanusso AU - Sergio Ferrari AU - Sara Mariotto AU - Alessandro Pezzini AU - Roberto Gasparotti AU - Ciro Paolillo AU - Alessandro Padovani TI - COVID-19 impact on consecutive neurological patients admitted to the emergency department AID - 10.1101/2020.05.23.20110650 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.23.20110650 4099 - http://medrxiv.org/content/early/2020/05/26/2020.05.23.20110650.short 4100 - http://medrxiv.org/content/early/2020/05/26/2020.05.23.20110650.full AB - Objective Aim of this study was to analyse the impact of COVID-19 on clinical and laboratory findings and outcome of neurological patients consecutively admitted to the emergency department (ED) of a tertiary hub center.Methods All adult patients consecutively admitted to the ED for neurological manifestations from February 20th through April 30th 2020 at Spedali Civili of Brescia entered the study. Demographic, clinical, and laboratory data were extracted from medical records and compared between patients with and without COVID-19.Results Out of 505 consecutively patients evaluated at ED with neurological symptoms, 147 (29.1%) tested positive for SARS-CoV-2. These patients displayed at triage higher values of CRP, AST, ALT, and fibrinogen but not lymphopenia (p<0.05). They were older (73.1 ± 12.4 vs 65.1 ± 18.9 years, p=0.001) had higher frequency of stroke (34.7% vs 29.3%), encephalitis/meningitis (9.5% vs 1.9%) and delirium (16.3% vs 5.0%). Compared to patients without COVID, they were more frequently hospitalized (91.2% vs 69.3%, p<0.0001) and showed higher mortality rates (29.7% vs 1.8%, p<0.0.001) and discharge disability, independently from age.Conclusions COVID-19 impacts on clinical presentation of neurological disorders, with higher frequency of stroke, encephalitis and delirium, and was strongly associated with increased hospitalisation, mortality and disability.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the local ethics committee of ASST Spedali Civili di Brescia Hospital (NP 4067, approved 08.05.2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are made available from authors upon reasonable request